医学
免疫系统
2型糖尿病
糖尿病
免疫学
炎症
危险分层
2型糖尿病
生物信息学
个性化医疗
精密医学
疾病
风险评估
淋巴细胞
内科学
仿形(计算机编程)
淋巴细胞亚群
银屑病
全身炎症
作者
Tran Bao Vuong,Chloé Delépine,Jacqueline M. Ratter-Rieck,Elisabetta Rinaldi,Jean‐Baptiste Julla,Emma Creussot,Marc Diedisheim,Violeta Raverdy,Elise Liu,Justus S. Fischer,Matthias Hepprich,Fawaz Alzaïd,Camille Blériot,Étienne Becht,Clémence Cornuot,Joe De Keizer,macine-bachir abdelouahab,Magali Chiral,Rebecca Pfeil,Polina Lipaeva
标识
DOI:10.1016/j.cmet.2026.07.027
摘要
Abstract Type 2 diabetes (T2D) is a heterogeneous disease, yet current classifications fail to capture its complexity or enable precision care. Here, we introduce a clinically scalable, immune-based endotyping strategy using routine blood immune cell counts - neutrophils, lymphocytes, and monocytes - from over 1,500 individuals with newly diagnosed T2D across three independent longitudinal European cohorts. Unsupervised clustering identified four consistent and clinically meaningful immune endotypes: Severe Inflammatory Diabetes (SIND), Mild Inflammatory Diabetes (MIND), Lymphocyte-Rich Diabetes (LYRD), and Lymphocyte-Deficient Diabetes (LYDD), that named immunotypes. These endotypes were associated with divergent long-term outcomes, with SIND and LYDD showing increased cardiovascular, renal, and mortality risks, and MIND and LYRD linked to more favorable trajectories. Multi-omic profiling revealed endotype-specific inflammatory signatures, including selective expansion of CCR2hi and CD39hi classical monocytes in the SIND endotype. Integration with single-cell RNA-seq uncovered distinct monocyte subsets in SIND, enriched for chemotaxis and myeloid activation transcriptional programs, alongside skewed adaptive immunity. Strikingly, this pro-inflammatory immune profile was attenuated by IL-1β antagonism and bariatric surgery-induced diabetes remission, underscoring its therapeutic relevance. These findings position immune-based endotyping as a robust and accessible tool to stratify risk, uncover disease mechanisms, and guide personalized intervention strategies in T2D.
科研通智能强力驱动
Strongly Powered by AbleSci AI